Implantable Exenatide (Byetta)
- Have type 2 diabetes
- Are treated with diet and exercise OR oral anti-diabetic agents
- And have an A1C ≥ 7.5
You may be eligible to participate in a clinical study for a new investigation implantable version of the FDA approved medication Exenatide (Byetta).
For more information, please contact Marie-Laure Névoret, MD or 757-446-5106.
This study was approved by an EVMS IRB (Pro-00007502 and Pro-00008112)